AstraZeneca (LON:AZN) Stock Price Passes Above 200-Day Moving Average – What’s Next?

AstraZeneca PLC (LON:AZN)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of £135.74 and traded as high as £154.32. AstraZeneca shares last traded at £153.16, with a volume of 2,036,970 shares traded.

Analyst Ratings Changes

AZN has been the subject of several recent analyst reports. Shore Capital Group reiterated a “buy” rating on shares of AstraZeneca in a research note on Friday, January 16th. Berenberg Bank upped their target price on shares of AstraZeneca from £145 to £160 and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of AstraZeneca from £105 to £110 and gave the company a “sell” rating in a research report on Thursday, January 15th. Citigroup started coverage on AstraZeneca in a research note on Tuesday, January 27th. They set a “buy” rating and a £170 price target on the stock. Finally, JPMorgan Chase & Co. restated an “overweight” rating on shares of AstraZeneca in a report on Thursday, January 15th. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of £145.83.

AstraZeneca Stock Up 2.0%

The company has a current ratio of 0.94, a quick ratio of 0.59 and a debt-to-equity ratio of 60.87. The firm has a 50 day moving average price of £145.02 and a 200-day moving average price of £135.74. The firm has a market cap of £237.51 billion, a price-to-earnings ratio of 23.42, a P/E/G ratio of 0.86 and a beta of 0.23.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.